K202101: GEM Hemochron 100 System, GEM Hemochron 100 Activated Clotting Time Plus Test (ACT+), GEM Hemochron 100 Low Range Activated Clotting Time Te (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K202101 (GEM Hemochron 100 System, GEM Hemochron 100 Activated Clotting Time Plus Test (ACT+), GEM Hemochron 100 Low Range Activated Clotting Time Te, cleared 2021-12-29 for Accriva Diagnostics, Inc.) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K202101 |
| Cleared Device Trade / Generic Name | GEM Hemochron 100 System, GEM Hemochron 100 Activated Clotting Time Plus Test (ACT+), GEM Hemochron 100 Low Range Activated Clotting Time Te |
| FDA Applicant on Filing | Accriva Diagnostics, Inc. |
| FDA 3-Letter Product Classification | Product Code JPA |
| FDA Substantial Equivalence Decision Date | 2021-12-29 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Inspect consolidated manufacturer lineage at Accriva Diagnostics, Inc., compare peer devices under FDA Product Code JPA, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.